BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22682482)

  • 1. [Cystic fibrosis and other channelopathies].
    Edelman A; Saussereau E
    Arch Pediatr; 2012 May; 19 Suppl 1():S13-6. PubMed ID: 22682482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis and CFTR.
    Greger R; Schreiber R; Mall M; Wissner A; Hopf A; Briel M; Bleich M; Warth R; Kunzelmann K
    Pflugers Arch; 2001; 443 Suppl 1():S3-7. PubMed ID: 11845294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
    Li C; Naren AP
    Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis and related diseases of the pancreas.
    Naruse S; Kitagawa M; Ishiguro H; Fujiki K; Hayakawa T
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):511-26. PubMed ID: 12079272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocyte biology and cystic fibrosis liver disease.
    Feranchak AP; Sokol RJ
    Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR.
    Egan M; Flotte T; Afione S; Solow R; Zeitlin PL; Carter BJ; Guggino WB
    Nature; 1992 Aug; 358(6387):581-4. PubMed ID: 1380129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis].
    Chinet T
    Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mGluR1 interacts with cystic fibrosis transmembrane conductance regulator and modulates the secretion of IL-10 in cystic fibrosis peripheral lymphocytes.
    Shanshiashvili LV; Dabrundashvili N; Natsvlishvili N; Kvaratskhelia E; Zhuravliova E; Barbakadze T; Koriauli S; Maisuradze E; Topuria T; Mikeladze DG
    Mol Immunol; 2012 Jul; 51(3-4):310-5. PubMed ID: 22520513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.
    Sheppard DN; Rich DP; Ostedgaard LS; Gregory RJ; Smith AE; Welsh MJ
    Nature; 1993 Mar; 362(6416):160-4. PubMed ID: 7680769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy.
    Kim Chiaw P; Eckford PD; Bear CE
    Essays Biochem; 2011 Sep; 50(1):233-48. PubMed ID: 21967060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship.
    Gabriel SE; Clarke LL; Boucher RC; Stutts MJ
    Nature; 1993 May; 363(6426):263-8. PubMed ID: 7683773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.